Cleveland Clinic researchers have discovered the first example of a genetic alteration that increases the conversion of precursor steroids to 5α-dihydrotestosterone (DHT), permitting prostate tumors to grow in the absence of gonadal testosterone.
A trial studying renal denervation for resistant hypertension and a new Resistant Hypertension Clinic are advancing understanding of this condition.
Tubeless percutaneous nephrolithotomy is effective and safe regardless of intraoperative issues that were previously used as exclusionary criteria for this approach.
Results help identify active surveillance candidates
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
After a national search, Cleveland Clinic’s Board of Governors has chosen Robert Heyka, MD, a 27-year veteran of the institution’s medical staff, as Chair of the Department of Nephrology and Hypertension.
Insights from 2-D MRS studies have ignited a quest to study chemical changes in large volumes of brain simultaneously using 3-D PEPSI imaging. And they hint at what’s possible with MRS at 7-tesla field strength.
The novel CAREN system allows safe challenging of rehab patients through scenarios in an immersive virtual environment. Early use centers on Parkinson disease and MS, but clinical and research applications may be boundless.
Cleveland Clinic surgeons share the first known report of the combined use of three advanced operative tools for intractable focal partial epilepsy. Recovery was swift for the 19-year-old patient.
7-tesla MRI imaging is taking neuropsychiatric research into new territory with awe-inspiring resolution — and the story of what’s involved in scanner installation is pretty impressive too.
Jeffrey Ponsky, MD, has rejoined Cleveland Clinic in a newly created role focused on his passion for hands-on clinical innovations. Hear his thoughts on what’s next in minimally invasive surgery.